Drug stocks climb; Bayer gains on approval
May 20, 2009 at 10:22 AM EDT
BOSTON (MarketWatch) -- Drug stocks climbed into positive territory early Wednesday as shares of Bayer AG gained ground on news that its liver cancer treatment Nexavar had won market approval in Japan.
